Home Healthcare IT Asia-Pacific Medical Cannabis Market Size, Share and Forecast to 2033

Asia-Pacific Medical Cannabis Market Size & Outlook, 2025-2033

Asia-Pacific Medical Cannabis Market Size, Share & Trends Analysis Report By Product Type (Solids, Dissolvable/Powders, Oil, Ointments and Creams), By Derivative (Cannabidiol, Tetrahydrocannabinol), By Route of Administrative (Inhalation, Oral, Topical), By Applications (Pain Management, Neurological Health Management, Mental Health Management), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and By Country(China, Korea, Japan, India, Australia, Taiwan, South East Asia, Rest of Asia-Pacific) Forecasts, 2025-2033

Report Code: SRHI54557DR
Last Updated : Jun, 2023
Pages : 110
Author : Debashree Bora
Format : PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  2. ESG Trends
  3. ESG Trends
    1. Introduction
    2. By Product
      1. Introduction
        1. Product By Value
      2. Flowers
        1. By Value
      3. Concentrates
        1. By Value
      4. Edibles
        1. By Value
      5. Topical and Tinctures
        1. By Value
      6. Others
        1. By Value
    3. By Derivative
      1. Introduction
        1. Derivative By Value
      2. Cannabidiol (CBD)
        1. By Value
      3. Tetrahydrocannabinol (THC)
        1. By Value
    4. By Route of Administration
      1. Introduction
        1. Route of Administration By Value
      2. Inhalation
        1. By Value
      3. Oral
        1. By Value
      4. Topical
        1. By Value
    5. By Applications
      1. Introduction
        1. Applications By Value
      2. Pain Management
        1. By Value
      3. Neurological Health Management
        1. By Value
      4. Mental Health Management
        1. By Value
      5. Others
        1. By Value
    6. By Distribution Channel
      1. Introduction
        1. Distribution Channel By Value
      2. Hospital Pharmacies
        1. By Value
      3. Retail Pharmacies
        1. By Value
      4. Online Pharmacies
        1. By Value
    7. China
      1. By Product
        1. Introduction
          1. Product By Value
        2. Flowers
          1. By Value
        3. Concentrates
          1. By Value
        4. Edibles
          1. By Value
        5. Topical and Tinctures
          1. By Value
        6. Others
          1. By Value
      2. By Derivative
        1. Introduction
          1. Derivative By Value
        2. Cannabidiol (CBD)
          1. By Value
        3. Tetrahydrocannabinol (THC)
          1. By Value
      3. By Route of Administration
        1. Introduction
          1. Route of Administration By Value
        2. Inhalation
          1. By Value
        3. Oral
          1. By Value
        4. Topical
          1. By Value
      4. By Applications
        1. Introduction
          1. Applications By Value
        2. Pain Management
          1. By Value
        3. Neurological Health Management
          1. By Value
        4. Mental Health Management
          1. By Value
        5. Others
          1. By Value
      5. By Distribution Channel
        1. Introduction
          1. Distribution Channel By Value
        2. Hospital Pharmacies
          1. By Value
        3. Retail Pharmacies
          1. By Value
        4. Online Pharmacies
          1. By Value
    8. Korea
    9. Japan
    10. India
    11. Australia
    12. Taiwan
    13. South East Asia
    14. Rest of Asia-Pacific
    1. Asia-Pacific Medical Cannabis Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Canopy Growth Corporation
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Cannasr Sativa Inc.
    3. Gw Pharmaceuticals Plc
    4. Emerald Health Therapeutics
    5. Tilray Inc.
    6. Aurora Cannasr Inc.
    7. Cara Therapeutics
    8. Medical Marijuana Inc.
    9. Gb Sciences Inc.
    10. Canndoc.
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  4. Disclaimer

Available for purchase with detailed segment data, forecasts, and regional insights.

Get This Report

Download Free Sample

Note: Please ensure you provide an active email address as we will be sending sample details via email.
The button will be active once the above form is filled

We are featured on :

Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
DMCA.com Protection Status
Secure Payments:
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.